Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Multiple myeloma is a representative blood cancer along with lymphoma and leukemia. Multiple myeloma is the second most common blood cancer after lymphoma in Korea, and it is a more common disease ...

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

Drug-Delivering Aptamers Target Leukemia Stem Cells for One-Two Knockout ... New Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma Jan. 14, 2025 — A team of researchers ...

Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't ...

Melphalan flufenamide (melflufen) is approved in Europe for relapsed/refractory multiple myeloma, but the FDA withdrew its ...

HAVING DISCUSSED IMPORTANT lymphoma and chronic lymphocytic leukemia abstracts from the 66th American Society of Hematology ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

Support grows for a new test designed to monitor individuals at risk of multiple myeloma, aiming for earlier detection and ...